We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-18.55%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$656M
AUM Growth
+$127M
Cap. Flow
-$219M
Cap. Flow %
-33.35%
Top 10 Hldgs %
78.61%
Holding
100
New
17
Increased
8
Reduced
19
Closed
46

Top Buys

Rank Stock Value
1
ATEC icon
Alphatec Holdings
ATEC
+$3.65M
2
EVH icon
Evolent Health
EVH
+$1.83M
3
DVA icon
DaVita
DVA
+$1.15M
4
MYGN icon
Myriad Genetics
MYGN
+$865K
5
CHWY icon
Chewy
CHWY
+$808K

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$21.6M
2
KVUE icon
Kenvue
KVUE
+$9.06M
3
NTRA icon
Natera
NTRA
+$7.75M
4
QTRX icon
Quanterix
QTRX
+$7.3M
5
MTD icon
Mettler-Toledo International
MTD
+$7.2M

Sector Composition

Rank Sector Weight
1 Healthcare 63.58%
2 Consumer Discretionary 0.15%
3 Consumer Staples 0%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTD icon
76
Mettler-Toledo International
MTD
$28.8B
– –
-6,500
Closed -$7.2M
MTD icon
77
PUT
Mettler-Toledo International
MTD
$28.8B
– –
-11,200
Closed -$12.4M
NSPR icon
78
CALL
InspireMD
NSPR
$40.3M
– –
-93,100
Closed -$304K
OEF icon
79
PUT
iShares S&P 100 ETF
OEF
$20.4B
– –
-130,000
Closed -$23M
OM icon
80
CALL
Outset Medical
OM
$84.6M
– –
-5,667
Closed -$925K
OM icon
81
Outset Medical
OM
$84.6M
– –
-9,222
Closed -$1.5M
ORGO icon
82
CALL
Organogenesis Holdings
ORGO
$233M
– –
-100,000
Closed -$318K
ORGO icon
83
Organogenesis Holdings
ORGO
$233M
– –
-301,697
Closed -$959K
PACB icon
84
Pacific Biosciences
PACB
$345M
– –
-415,000
Closed -$3.47M
PODD icon
85
PUT
Insulet
PODD
$10.1B
– –
-20,000
Closed -$3.19M
RGEN icon
86
Repligen
RGEN
$9.35B
– –
-13,000
Closed -$2.07M
RMD icon
87
PUT
ResMed
RMD
$32.8B
– –
-97,500
Closed -$14.4M
SDGR icon
88
Schrodinger
SDGR
$1.39B
– –
-87,964
Closed -$2.49M
TELA icon
89
TELA Bio
TELA
$32.3M
– –
-337,175
Closed -$2.7M
THC icon
90
PUT
Tenet Healthcare
THC
$21.5B
– –
-50,000
Closed -$3.29M
TNDM icon
91
PUT
Tandem Diabetes Care
TNDM
$1.63B
– –
-81,800
Closed -$1.7M
WAT icon
92
PUT
Waters Corp
WAT
$40.9B
– –
-10,000
Closed -$2.74M
XNTK icon
93
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.25B
– –
-100,000
Closed -$7.3M
ZBH icon
94
CALL
Zimmer Biomet
ZBH
$18.7B
– –
-100,000
Closed -$11.2M
RCM
95
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-245,929
Closed -$3.71M
OLK
96
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
– –
-88,772
Closed -$1.31M
SWAV
97
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-27,500
Closed -$5.48M
NSTG
98
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-590,800
Closed -$1.02M
SONX
99
DELISTED
Sonendo, Inc.
SONX
– –
-4,663,907
Closed -$3.48M
DENT
100
CALL
DELISTED
AdvisorShares Dent Tactical ETF
DENT
– –
-2,500,000
Closed -$19.9M
1 2 3
4

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2023 Portfolio in Review

As of Q4 2023, Pura Vida Investments held 100 positions worth $656M, up 24% from $529M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Pura Vida Investments withdrew a net $219M in Q4 2023, closing 46 positions and reducing 19 holdings. Its most notable exit was Glaukos, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Pura Vida Investments opened a new position in Alphatec Holdings worth $4.61M.

  • Pura Vida Investments's largest Q4 2023 buy was Alphatec Holdings: 305,000 shares worth $4.61M.
  • Pura Vida Investments added most to DexCom in Q4 2023, an estimated $792K increase.
  • Pura Vida Investments's biggest Q4 2023 reduction was Natera, cutting an estimated $7.75M.
  • Pura Vida Investments fully exited Glaukos in Q4 2023, selling an estimated $21.6M.
  • Pura Vida Investments's ten largest holdings make up 79% of its $656M portfolio in Q4 2023.
  • Pura Vida Investments opened 17 new positions and closed 46 in Q4 2023.
  • Pura Vida Investments's portfolio value rose 24% quarter-over-quarter to $656M.

Based on Pura Vida Investments's 13F filing for Q4 2023, filed 13 Feb 2024.